Zhang, W., Tong, Q., Sun, J., Hua, X., Long, Z., Deng, J., . . . Lin, H. (2019). 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer. Front Oncol.
Citação norma ChicagoZhang, Wen-Wen, et al. "21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer." Front Oncol 2019.
MLA CitationZhang, Wen-Wen, et al. "21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer." Front Oncol 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.